Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ECR Pharmaceuticals, a subsidiary of Hi-Tech Pharmacal Co, has launched Zolpimist Oral Spray, a novel delivery system of zolpidem tartrate, in the US.
Subscribe to our email newsletter
The Zolpimist Oral Spray unit contains 60 metered sprays and provides the flexibility of administering either a 5 or 10 mg dose of the zolpidem active ingredient, ECR Pharmaceuticals said.
As with most prescription hypnotic agents, Zolpimist Oral Spray is federally classified as a CIV controlled substance and is only available by prescription.
Hi-Tech president and CEO David Seltzer said Zolpimist is a significant addition to ECR and reflects their continuing commitment to build this segment of their business through the marketing of widely used, innovative products.